Cysteamine Hydrochloride → (1)Benzothieno(2,3-f)-1,4-thiazepin-5(2H)-one, 3,4-dihydro-9-methoxy-
反応式
Cl[C:2]1[C:3]2[CH:14]=[C:13]([O:15][CH3:16])[CH:12]=[CH:11][C:4]=2[S:5][C:6]=1[C:7]([O:9]C)=O.ClC1C2C=C(OC)C=CC=2SC=1C(Cl)=O.Cl.[NH2:33][CH2:34][CH2:35][SH:36].C1CCN2C(=NCCC2)CC1>CN(C=O)C.C(OCC)(=O)C.CO>[CH3:16][O:15][C:13]1[CH:12]=[CH:11][C:4]2[S:5][C:6]3[C:7](=[O:9])[NH:33][CH2:34][CH2:35][S:36][C:2]=3[C:3]=2[CH:14]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
To a room temperature solution of methyl 3-chloro-5-methoxy-benzo[b]thiophene-2-carboxylate (500 mg, 1.95 mmol) [prepared by reaction of the known 3-chloro-5-methoxy-benzo[b]thiophene-2-carbonyl chloride with methanol- [J. Med. Chem., 35:958 (1992)]] in 20 mL of DMF is added cysteamine-HCl (885 mg, 7.79 mmol) followed by DBU (2.33 mL, 15.58 mmol). The reaction mixture is stirred at room temperature for 1.5 hours then warmed to 70° C. The mixture is diluted with ethyl acetate and washed with aqueous HCl, water and brine. The organic layer is dried over MgSO4, filtered and concentrated in vacuo. The crude product is recrystallized from hexane and ethyl acetate to provide 2,3-dihydro-9-methoxy[1]benzothieno[2,3-f]-1,4-thiazepin-5(4H)-one in 74% yield, mp 209°-209.5° C.
後処理
- temperaturethen warmed to 70° C
- washwashed with aqueous HCl, water and brine
- dry with materialThe organic layer is dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe crude product is recrystallized from hexane and ethyl acetate
出典と根拠
- ORDレコード
- ord-f39555394cf64d15a66404b786b79216
- 出典データセット
- uspto-grants-1997_12
- 特許番号
- US05703069
反応ノート
読み込み中…